Literature DB >> 8058741

Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition.

J Xu1, K Matsuzaki, K McKeehan, F Wang, M Kan, W L McKeehan.   

Abstract

Heterodimers of types I and II serine/threonine kinase receptor monomers compose the active receptor complex for ligands of the transforming growth factor beta family. Here we show that the genomic organization of coding sequences for the intracellular domain of a widely expressed type I serine/threonine kinase receptor is similar to that of the activin type II receptor gene. The genomic structure and cDNA clones indicate that poly(A) addition to alternative exons at each of three carboxyl-terminal coding exon-intron junctions may be a common feature of both type I and II receptor genes. The predicted products are monomers truncated at kinase subdomains VII, IX, and X which vary in kinase activity and potential serine, threonine, and tyrosine phosphorylation sites. These results suggest that combinations of variants that affect the signal-transducing intracellular kinase domain of both type I and II receptor monomers within the transforming growth factor beta ligand family may add to the heterogeneity of biological effects of individual ligands in the family.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058741      PMCID: PMC44523          DOI: 10.1073/pnas.91.17.7957

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.

Authors:  H Y Lin; X F Wang; E Ng-Eaton; R A Weinberg; H F Lodish
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

2.  Structure of the mouse activin receptor type II gene.

Authors:  M M Matzuk; A Bradley
Journal:  Biochem Biophys Res Commun       Date:  1992-05-29       Impact factor: 3.575

3.  Expression cloning of an activin receptor, a predicted transmembrane serine kinase.

Authors:  L S Mathews; W W Vale
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

4.  Fibroblast growth factor receptors from liver vary in three structural domains.

Authors:  J Z Hou; M K Kan; K McKeehan; G McBride; P Adams; W L McKeehan
Journal:  Science       Date:  1991-02-08       Impact factor: 47.728

5.  Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family.

Authors:  W W He; M L Gustafson; S Hirobe; P K Donahoe
Journal:  Dev Dyn       Date:  1993-02       Impact factor: 3.780

6.  Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.

Authors:  R Ebner; R H Chen; S Lawler; T Zioncheck; R Derynck
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

7.  Exon skipping causes alteration of the COOH-terminus and deletion of the phospholipase C gamma 1 interaction site in the FGF receptor 2 kinase in normal prostate epithelial cells.

Authors:  G Yan; G McBride; W L McKeehan
Journal:  Biochem Biophys Res Commun       Date:  1993-07-15       Impact factor: 3.575

8.  Expression of human tyrosine kinase-negative epidermal growth factor receptor amplifies signaling through endogenous murine epidermal growth factor receptor.

Authors:  N Hack; A Sue-A-Quan; G B Mills; K L Skorecki
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

9.  Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.

Authors:  P Franzén; P ten Dijke; H Ichijo; H Yamashita; P Schulz; C H Heldin; K Miyazono
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.

Authors:  L Attisano; J Cárcamo; F Ventura; F M Weis; J Massagué; J L Wrana
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  7 in total

1.  Structure and chromosomal locations of mouse steroid receptor coactivator gene family.

Authors:  G Ning; V Jurecic; A Baldini; J Xu
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-09       Impact factor: 2.416

2.  Kinase-inactive splice variants of the activin type I receptor.

Authors:  K McKeehan; W I McKeehan; J Xu; L Liao
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-03       Impact factor: 2.416

3.  Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells.

Authors:  K Matsuzaki; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

4.  Schistosoma mansoni TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target gene.

Authors:  Ahmed Osman; Edward G Niles; Sergio Verjovski-Almeida; Philip T LoVerde
Journal:  PLoS Pathog       Date:  2006-06-16       Impact factor: 6.823

5.  Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma.

Authors:  I Ito; T Minegishi; J Fukuda; H Shinozaki; N Auersperg; P C Leung
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

6.  Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development.

Authors:  M Matsushita; K Matsuzaki; M Date; T Watanabe; K Shibano; T Nakagawa; S Yanagitani; Y Amoh; H Takemoto; N Ogata; C Yamamoto; Y Kubota; T Seki; H Inokuchi; M Nishizawa; H Takada; T Sawamura; A Okamura; K Inoue
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

7.  Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.

Authors:  H Yamashita; P ten Dijke; D Huylebroeck; T K Sampath; M Andries; J C Smith; C H Heldin; K Miyazono
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.